Orbimed Advisors LLC Ars Pharmaceuticals, Inc. Comm Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Orbimed Advisors LLC holds 8,288,510 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,288,510
Previous 9,240,887 10.31%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
N/A
-952,377 Reduced 10.31%
8,288,510 $0
Q3 2023

Nov 14, 2023
BUY
N/A
500,000 Added 5.72%
9,240,887 $0
Q4 2020

Feb 16, 2021
BUY
N/A
8,740,887 New
8,740,887 $405 Million

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email